Welcome to CompuMed’s Investor relations. CompuMed, Inc. is a Delaware company headquartered in Los Angeles, California. Our stock is traded under the symbol CMPD on the OTCPink exchange operated by OTC Markets.
For the Company’s latest corporate financial and required filings please click here.
Contact our investor relations department for additional information at 310-258-5000 or by email [email protected].
CompuMed Announces Purchase of Shares held by VI Capital and Changes in the Board of Directors
CompuMed Announces Approval and Amendment to Reduce Authorized Shares
CompuMed CEO Lee Keddie Joins The Alliance National Innovation Leadership Council
CompuMed Announces Approval of Reverse Stock Split
CompuMed Inc. Announces Results of Shareholder Voting
CompuMed, Inc. Announces Fiscal 2021 Forth Quarter Results
CompuMed, Inc. Announces Fiscal 2021 Third Quarter Results
CompuMed Announces Conversion of Series D Preferred Stock
COVID-19: CompuMed Continuity of Telemedicine Diagnostic Services
CompuMed Announces Redemption Notice for Class A and Class B Preferred Stock